BlackRock Group’s Novartis NVS Stock Holding History

BlackRock Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-19,896	Closed	-$1.61M	–	2868
2014 Q2	$1.61M	Buy	+19,896	New	+$1.56M	﹤0.01%	1573

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Group's NVS Position: Q3 2014 in Review

BlackRock Group sold out of Novartis (NVS) in Q3 2014, closing a stake of 19,896 shares — an estimated $1.61M sold.

BlackRock Group first reported a position in NVS in Q2 2014 and held it in 1 quarter. The position peaked at $1.61M in Q2 2014. 874 funds tracked by Wall St. Rank hold NVS as of Q3 2014.

BlackRock Group reported no remaining Novartis position as of Q3 2014 after selling out during the quarter.
BlackRock Group sold 19,896 Novartis shares in Q3 2014, an estimated $1.61M.
BlackRock Group first reported a position in Novartis in Q2 2014 and held it in 1 quarter.
BlackRock Group's Novartis position peaked at $1.61M in Q2 2014.
874 funds tracked by Wall St. Rank held Novartis as of Q3 2014.

Based on BlackRock Group's 13F filing for Q3 2014, filed 29 Oct 2014.